Andreas Holm Mattsson | Chief AI Officer
Evaxion Biotech

Andreas Holm Mattsson serves as Chief AI Officer at Evaxion, where he’s been at the forefront in silico-based vaccine target discovery. He has played a key role in developing Evaxion’s innovative AI-immunologyTM platform, a proprietary AI technology for identifying novel vaccine targets for cancer and infectious diseases. 
Andreas brings a strong educational background in bioinformatics from the Technical University of Denmark and has previously worked at Novo Nordisk.
Since founding Evaxion in 2008, he has been an essential part of the company’s growth, serving in various executive roles. His journey in the biotech industry reflects his dedication to advancing science and improving healthcare through innovative solutions.